๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

External counterpulsation: Coronary hemodynamics and use in treatment of patients with stable angina pectoris

โœ Scribed by Solignac, Alain ;Ferguson, Ronald J. ;Bourassa, Martial G.


Publisher
John Wiley and Sons
Year
1977
Tongue
English
Weight
482 KB
Volume
3
Category
Article
ISSN
0098-6569

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

External pressure counterpulsation (ECP) has been reported to improve the clinical status of patients with angina pectoris. To document the mechanisms for such an improvement left ventricular oxygen consumption and lactate metabolism, coronary sinus blood flow, and cardiac index were studied in 10 patients with angina pectoris 1) prior to and during ECP; and 2) during right atrial pacing before and after 4 consecutive 2โ€hour sessions of ECP treatment. During ECP peak early and mean arterial diastolic pressures were significantly raised above control values by 32 and 13% respectively. However, coronary sinus blood flow, left ventricular oxygen consumption and left ventricular lactate extraction, mean systolic arterial pressure and cardiac index were not significantly altered by ECP. Right atrial pacing at 140 beats/min increased coronary sinus blood flow 70% over control values and induced angina and ischemic ST segment changes in 8 patients before and after 4 consecutive treatments of ECP. ECP treatment did not significantly modify the above metabolic and hemodynamic responses at rest or during atrial pacing. Although 5 patients reported improvement in angina symptoms the effect was transitory. No significant improvement over pre ECPโ€treatment exercise angina threshold was observed immediately following or at 1 and 3 months post treatment. This method of noninvasive circulatory assistance appears to be of doubtful value in the management of patients with stable angina pectoris.


๐Ÿ“œ SIMILAR VOLUMES


Use of abciximab prevents microcirculato
โœ Francesco Prati; Piotr Kwiatkowski; Constantino Caroselli; Fabrizio Imola; Aless ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 63 KB ๐Ÿ‘ 2 views

The use of abciximab during percutaneous coronary angioplasty (PTCA) in patients with unstable angina (UA) prevents the postintervention enzyme surge and improves clinical outcomes, possibly by improving microcirculatory function. The aim of this quantitative myocardial blush grade (MBG) study was t

Ad Hoc percutaneous coronary interventio
โœ Ronald J. Krone; Richard E. Shaw; Lloyd W. Klein; James C. Blankenship; William ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 156 KB ๐Ÿ‘ 3 views

## Abstract Objective: To utilize the American College of Cardiology National Cardiovascular Data Registry (ACCโ€NCDRยฎ) to monitor the performance and safety of ad hoc PCIs. Background: The performance of ad hoc PCI remains controversial. Patients' preference, cost, and vascular access issues favor